Literature DB >> 17586686

Induction of cullin 7 by DNA damage attenuates p53 function.

Peter Jung1, Berlinda Verdoodt, Aaron Bailey, John R Yates, Antje Menssen, Heiko Hermeking.   

Abstract

The p53 tumor suppressor gene encodes a transcription factor, which is translationally and posttranslationally activated after DNA damage. In a proteomic screen for p53 interactors, we found that the cullin protein Cul7 efficiently associates with p53. After DNA damage, the level of Cul7 protein increased in a caffeine-sensitive, but p53-independent, manner. Down-regulation of Cul7 by conditional microRNA expression augmented p53-mediated inhibition of cell cycle progression. Ectopic expression of Cul7 inhibited activation of p53 by DNA damaging agents and sensitized cells to adriamycin. Although Cul7 recruited the F-box protein FBX29 to p53, the combined expression of Cul7/FBX29 did not promote ubiquitination and degradation of p53 in vivo. Therefore, the inhibition of p53 activity by Cul7 is presumably mediated by alternative mechanisms. The interplay between p53 and Cul7 resembles the negative feedback loop described for p53 and Mdm2. Pharmacological modulation of Cul7 function may allow the sensitization of cancer cells expressing wild-type p53 to genotoxic agents used in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17586686      PMCID: PMC2040908          DOI: 10.1073/pnas.0609467104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Regulation of p53 localization.

Authors:  S H Liang; M F Clarke
Journal:  Eur J Biochem       Date:  2001-05

2.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

Review 3.  The 14-3-3 cancer connection.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

4.  Parc: a cytoplasmic anchor for p53.

Authors:  Anatoly Y Nikolaev; Muyang Li; Norbert Puskas; Jun Qin; Wei Gu
Journal:  Cell       Date:  2003-01-10       Impact factor: 41.582

5.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells.

Authors:  Jian Yu; Zhenghe Wang; Kenneth W Kinzler; Bert Vogelstein; Lin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

6.  Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Authors:  Steven R Grossman; Maria E Deato; Chrystelle Brignone; Ho Man Chan; Andrew L Kung; Hideaki Tagami; Yoshihiro Nakatani; David M Livingston
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

7.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

8.  Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Authors:  J Parant; A Chavez-Reyes; N A Little; W Yan; V Reinke; A G Jochemsen; G Lozano
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

9.  Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.

Authors:  R Montes de Oca Luna; D S Wagner; G Lozano
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

10.  Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis.

Authors:  Takehiro Arai; Jocelyn S Kasper; Jeffrey R Skaar; Syed Hamid Ali; Chiaki Takahashi; James A DeCaprio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-06       Impact factor: 11.205

View more
  15 in total

1.  AP4 encodes a c-MYC-inducible repressor of p21.

Authors:  Peter Jung; Antje Menssen; Doris Mayr; Heiko Hermeking
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

2.  Quantitative proteomic analysis of cellular protein modulation upon inhibition of the NEDD8-activating enzyme by MLN4924.

Authors:  Hua Liao; Xiaozhen J Liu; Jonathan L Blank; David C Bouck; Hugues Bernard; Khristofer Garcia; Eric S Lightcap
Journal:  Mol Cell Proteomics       Date:  2011-08-26       Impact factor: 5.911

3.  FBG1 is a promiscuous ubiquitin ligase that sequesters APC2 and causes S-phase arrest.

Authors:  Hsiang Wen; Namhun Kim; Ernesto J Fuentes; Adam Mallinger; Pedro Gonzalez-Alegre; Kevin A Glenn
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

4.  The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1.

Authors:  Hua Wang; Yue Chen; Ping Lin; Lei Li; Guisheng Zhou; Guangchao Liu; Craig Logsdon; Jianping Jin; James L Abbruzzese; Tse-Hua Tan; Huamin Wang
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

5.  The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation.

Authors:  Xinsong Xu; Antonio Sarikas; Dora C Dias-Santagata; Georgia Dolios; Pascal J Lafontant; Shih-Chong Tsai; Wuqiang Zhu; Hidehiro Nakajima; Hisako O Nakajima; Loren J Field; Rong Wang; Zhen-Qiang Pan
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

Review 6.  The cullin7 E3 ubiquitin ligase: a novel player in growth control.

Authors:  Antonio Sarikas; Xinsong Xu; Loren J Field; Zhen-Qiang Pan
Journal:  Cell Cycle       Date:  2008-10-04       Impact factor: 4.534

7.  The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1.

Authors:  Dan Hanson; Philip G Murray; Amit Sud; Samia A Temtamy; Mona Aglan; Andrea Superti-Furga; Sue E Holder; Jill Urquhart; Emma Hilton; Forbes D C Manson; Peter Scambler; Graeme C M Black; Peter E Clayton
Journal:  Am J Hum Genet       Date:  2009-05-28       Impact factor: 11.025

Review 8.  Cullin-RING E3 Ubiquitin Ligase 7 in Growth Control and Cancer.

Authors:  Zhen-Qiang Pan
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer.

Authors:  Ioannis A Voutsadakis
Journal:  Tumour Biol       Date:  2012-03-06

10.  Exome sequencing identifies CCDC8 mutations in 3-M syndrome, suggesting that CCDC8 contributes in a pathway with CUL7 and OBSL1 to control human growth.

Authors:  Dan Hanson; Philip G Murray; James O'Sullivan; Jill Urquhart; Sarah Daly; Sanjeev S Bhaskar; Leslie G Biesecker; Mars Skae; Claire Smith; Trevor Cole; Jeremy Kirk; Kate Chandler; Helen Kingston; Dian Donnai; Peter E Clayton; Graeme C M Black
Journal:  Am J Hum Genet       Date:  2011-07-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.